Search - tctmd.com

Displaying 521 - 540 of 610

Sort: Relevancy | Date

Female Mentors Likely Play Key Role in Boosting Numbers of Female ‘Corresponding’ Authors

News Daily News

Female Mentors Likely Play Key Role in Boosting Numbers of Female ‘Corresponding’ Authors

February 21, 2019

Quality of CAD Care Varies by Type of Medicare Coverage

News Daily News

Quality of CAD Care Varies by Type of Medicare Coverage

February 20, 2019

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

February 20, 2019

Rohan Kalathiya, MD

News Featured Fellow

Rohan Kalathiya, MD

Yael L. Maxwell

February 19, 2019

Interventional and Pharmacological Crossroads: our decision

Presentation JIM 2019

Interventional and Pharmacological Crossroads: our decision

Presenter: Marco Ferlini

February 15, 2019

A Decapitated Left Main Coronary Stent

Presentation JIM 2019

A Decapitated Left Main Coronary Stent

Presenter: Chin Chee Yang

February 15, 2019

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

News Daily News

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

February 15, 2019

Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes?

News Conference News ISC 2019

Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes?

February 14, 2019

Abnormal Coronary Reactivity in Women Portends Added CV, Death Risk in the Next Decade

News Daily News

Abnormal Coronary Reactivity in Women Portends Added CV, Death Risk in the Next Decade

February 13, 2019

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

February 13, 2019

Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable

News Daily News

Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable

February 12, 2019

Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade

News Conference News ISC 2019

Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade

February 11, 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

February 08, 2019

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

News Daily News

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Michael O'Riordan

February 08, 2019

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

News Conference News ISET 2019

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

February 07, 2019

Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients

News Conference News ISC 2019

Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients

February 07, 2019

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

News Conference News STS 2019

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

Yael L. Maxwell

February 06, 2019

Opioid Epidemic Brings Higher Rates of Endocarditis, Stroke

News Conference News ISC 2019

Opioid Epidemic Brings Higher Rates of Endocarditis, Stroke

February 06, 2019

Acute PE Algorithm in the Works to Guide Clinicians’ Complex Decision-making

News Conference News ISET 2019

Acute PE Algorithm in the Works to Guide Clinicians’ Complex Decision-making

February 05, 2019

One in Two Americans Have Cardiovascular Disease: AHA Stats

News Daily News

One in Two Americans Have Cardiovascular Disease: AHA Stats

Michael O'Riordan

February 04, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.